Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ANRG -- Anergen -- new CEO big chance ? -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (116)	12/14/1998 1:20:00 PM
From: WWS	Read Replies (1) \| Respond to of 123

CRXA is not cash rich. They show less than 5 million on their last 10Q. But the deal for ANRG also contained a clause for two current institutional investors to contribute 1.5 million in additional cash (in exchange for shares of CRXA) to future operations of the ANRG unit under CRXA. And, CRXA has the knack of getting others such as SKB to fund, through partnerships, part of development costs for specific products. I'd expect them to adopt a similar partnering model for their new ANRG unit.